PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation

Carcinogenesis

Volumn 30, Issue 5, 2009, Pages 824-831

  Appierto, Valentina ^a   Tiberio, Paola ^a   Villani, Maria Grazia ^a   Cavadini, Elena ^a   Formelli, Franca ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ASCORBIC ACID; FENRETINIDE; GROWTH DIFFERENTIATION FACTOR 15; GUAIACOL; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; X BOX BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DNA PRIMERS; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; FEMALE; FENRETINIDE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MAP KINASE KINASE 4; OVARIAN NEOPLASMS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 65549126847     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp067     Document Type: Article

References (41)

1. Nagy,L. et al. (1998) Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ., 5, 11-19.
2. Formelli,F. et al. (1996) Bioactivities of N-(4-hydroxyphenyl)retinamide and retinoyl beta-glucuronide. FASEB J. 10, 1014-1024.
3. Hail,N.Jr et al. (2006) Mechanisms of fenretinide-induced apoptosis. Apoptosis, 11, 1677-1694.
4. Veronesi,U. et al. (1999) Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J. Natl Cancer Inst., 91, 1847-1856.
5. De Palo,G. et al. (2002) Effect of fenretinide on ovarian carcinoma occurrence. Gynecol. Oncol., 86, 24-27.
6. Chiesa,F. et al. (2005) Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long-term results. Int. J. Cancer 115, 625-629.
7. Veronesi,U. et al. (2006) Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann. Oncol., 17, 1065-1071.
8. Clifford,J.L. et al. (1999) Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res., 59, 14-18.
9. Appierto,V. et al. (2007) Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells. Oncogene, 26, 3952-3962.
10. Bauskin,A.R. et al. (2000) The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J., 19, 2212-2220.
11. Baek,S.J. et al. (2006) Changes in gene expression contribute to cancer prevention by COX inhibitors. Prog. Lipid Res., 45, 1-16.
12. Okazaki,R. et al. (2006) Ionizing radiation enhances the expression of the nonsteroidal anti-inflammatory drug-activated gene (NAG1) by increasing the expression of TP53 in human colon cancer cells. Radiat. Res., 165, 125-130.
13. Newman,D. et al. (2003) Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids. Mol. Pharmacol., 63, 557-564.
14. Kadara,H. et al. (2006) Induction of GDF-15/NAG-1/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis. Cancer Biol. Ther., 5, 518-522.
15. Villani,M.G. et al. (2006) 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Cancer Res., 66, 3238-3247.
16. Suzuki,S. et al. (1999) Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Oncogene, 18, 6380-6387.
17. Appierto,V. et al. (2004) Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells. Cell Death Differ., 1, 270-279.
18. Marciniak,S.J. et al. (2004) CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev., 18, 3066-3077.
19. Appierto,V. et al. (2001) Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line. Br. J. Cancer, 84, 1528-1534.
20. Supino,R. et al. (1996) Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int. J. Cancer, 65, 491-497.
21. Boyce,M. et al. (2006) Cellular response to endoplasmic reticulum stress: A matter of life or death. Cell Death Differ., 13, 363-373.
22. Boyce,M. et al. (2005) A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science, 307 935-939.
23. Wu,J. et al. (2006) From acute ER stress to physiological role of the Unfolded Protein Response. Cell Death Differ., 13, 374-384.
24. Shen,H.M. et al. (2006) JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med., 40, 928-939.
25. Kim,R. et al. (2006) Role of the unfolded protein response in cell death. Apoptosis, 11, 5-13.
26. Rouse,J. et al. (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell, 78, 1027-1037.
27. Chen,C.Y. et al. (1998) Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science, 280, 1945-1949.
28. Dandrea,T. et al. (2004) The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: Relationship to DNA damage, cell cycle arrest, and caspase activation. Free Radic. Biol. Med., 36, 881-896.
29. Corazzari,M. et al. (2007) Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: The role of stress proteins ERdj5 and ERp57. Br. J. Cancer, 96, 1062-1071.
30. Kadara,H. et al. (2007) Induction of endoplasmic reticulum stress by the pro-apoptotic retinoid N-(4-Hydroxyphenyl)retinamide via a reactive oxygen species-dependent mechanism in human head and neck cancer cells. Cancer Biol. Ther., 6, 705-711.
31. Tiwari,M. et al. (2006) Mechanism of 4-HPR-induced apoptosis in glioma cells: Evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress. Carcinogenesis, 27 2047-2058.
32. Armstrong,J.L. et al. (2007) Role of NOXA in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours. Apoptosis 12, 613-622.
33. Haynes,C.M. et al. (2004) Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol. Cell, 15, 767-776.
34. Urano,F. et al. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287, 664-666.
35. Kim,H.J. et al. (2006) N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Oncogene, 25, 2785-2794.
36. Osone,S. et al. (2004) Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells. Int. J. Cancer, 112, 219-224.
37. Shimada,K. et al. (2002) Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells. Mol. Carcinog., 35, 127-137.
38. Chen,Y.R. et al. (1999) c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide. Mol. Pharmacol. 56, 1271-1279.
39. Eberhardt,W. et al. (2007) Modulation of mRNA stability as a novel therapeutic approach. Pharmacol. Ther., 114, 56-73.
40. Yamaguchi,K. et al. (2006) A novel peroxisome proliferator-activated receptor γ ligand, MCC-555, induces apoptosis via post-transcriptional regulation of NAG-1 in colorectal cancer cells. Mol. Cancer Ther., 5, 1352-1361.
41. Shim,M. et al. (2008) Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism. Mol. Cancer Ther., 7, 961-971.